CardioGen-82 150 mCi/1 (Rubidium Chloride RB-82 INJECTION, SOLUTION) 150 mCi/1

CardioGen-82 150 mCi/1 is a diagnostic injection solution containing Rubidium Chloride RB-82. It is used for imaging the heart to assess blood flow and function. This intravenous solution is manufactured by Bracco Diagnostics Inc.

Strength

150 mCi/1

Pack Size

1 INJECTION, SOLUTION in 1 PACKAGE (0270-0091-01)

Manufacturer / TM Owner

Bracco Diagnostics Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

CardioGen-82 150 mCi/1 is primarily used in medical imaging to evaluate heart function and blood flow. It is often employed in procedures like myocardial perfusion imaging, which helps in diagnosing and monitoring heart conditions. The solution is administered intravenously to provide clear images of the heart's activity.

Side Effects

When administered, CardioGen-82 150 mCi/1 may cause temporary flushing or a warm sensation. Some individuals might experience mild discomfort at the injection site. These effects are generally short-lived and subside quickly.

Precautions & Warnings

CardioGen-82 150 mCi/1 should be handled with care, following standard protocols for radioactive materials. It is important to ensure proper storage and disposal to minimize exposure. Patients should inform their healthcare provider about any allergies or medical conditions before administration.

Avoid Interactions

CardioGen-82 150 mCi/1 may interact with certain medications, particularly those that affect heart function or blood flow. It is advisable to consult with a healthcare provider regarding potential interactions, especially if taking other medications or supplements.

Frequently Asked Questions

CardioGen-82 150 mCi/1 is used for medical imaging to assess heart function and blood flow, often in procedures like myocardial perfusion imaging.

CardioGen-82 150 mCi/1 is administered intravenously by a healthcare professional in a controlled medical setting.

Common effects may include temporary flushing, a warm sensation, or mild discomfort at the injection site.

Yes, it should be handled with care, stored properly, and disposed of according to guidelines for radioactive materials.

Potential interactions may occur with medications affecting heart function or blood flow, so consult a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.